RxDoctor Payments Data

James Alexander, MD

Family Medicine · Marion, ILNPI 1114094851

Payments from drug & device makers

$10,882in general payments, 2019–2025

Across 749 payments — averaging $14.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • Novo Nordisk$1K
  • AstraZeneca$930
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$10,842100%
  • Education$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,882 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$126,006
Medicare patients
426
Services billed
1,564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$69,086
OzempicSemaglutide19$35,482
MounjaroTirzepatide27$31,752
JardianceEmpagliflozin31$30,844
FarxigaDapagliflozin Propanediol20$15,516
Repatha SureclickEvolocumab13$7,340
LinzessLinaclotide12$5,843
Pregabalin22$3,066
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen75$1,497
Levothyroxine Sodium106$1,115
Rosuvastatin Calcium94$1,105
Atorvastatin Calcium110$1,053
Potassium Chloride48$884
Esomeprazole Magnesium21$878
Lisinopril117$777

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,085$69,08655 claims
Novo NordiskOzempic$1,036$35,48219 claims
Lilly USA, LLCMounjaro$1,169$31,75227 claims
Boehringer IngelheimJardiance$517$30,84431 claims
AstraZenecaFarxiga$930$15,51620 claims
AbbVieLinzess, Synthroid$1,225$6,48724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Marion

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →